Bedeutung der Insulintherapie bei Menschen mit Diabetes mellitus Typ 2

In diabetology, a paradigm shift is taking place in the treatment of type 2 diabetes and the recommendations of the guidelines give insulin therapy a second-line status. The resulting aspects will be discussed in terms of what therapy of choice means for newly diagnosed diabetes and what possibilities arise from new therapy options. In addition, the experiences from Berlin disease management program (DMP) contracts for type 2 diabetes mellitus with the newly included services for insulin de-escalation, insulin avoidance, insulin escalation therapy in crisis situations, and diabetes remission are described and analyzed. These therapy options represent realistic support in simplifying therapy, combined with increasing acceptance among patients.